When Innovation and Commercialization Collide: A Patient Advocate View in Neuroblastoma.
J Clin Oncol
; 40(2): 120-126, 2022 01 10.
Article
in En
| MEDLINE
| ID: mdl-34793201
Full text:
1
Collection:
01-internacional
Database:
MEDLINE
Main subject:
Patient Advocacy
/
Commerce
/
Rare Diseases
/
Therapies, Investigational
/
Antineoplastic Agents, Immunological
/
Drug Development
/
Immunotherapy
/
Neuroblastoma
Type of study:
Prognostic_studies
/
Sysrev_observational_studies
Limits:
Humans
Language:
En
Journal:
J Clin Oncol
Year:
2022
Document type:
Article
Affiliation country:
United kingdom
Country of publication:
United States